Search by Drug Name or NDC
NDC 68788-8128-03 Bismuth Subsalicylate 262 mg 262 mg/1 Details
Bismuth Subsalicylate 262 mg 262 mg/1
Bismuth Subsalicylate 262 mg is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is BISMUTH SUBSALICYLATE.
MedlinePlus Drug Summary
Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
Related Packages: 68788-8128-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bismuth Subsalicylate
Product Information
NDC | 68788-8128 |
---|---|
Product ID | 68788-8128_a8f6bd6f-e972-434e-b0de-ab65b67a1ce4 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Bismuth Subsalicylate 262 mg |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bismuth Subsalicylate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 262 |
Active Ingredient Units | mg/1 |
Substance Name | BISMUTH SUBSALICYLATE |
Labeler Name | Preferred Pharmaceuticals Inc. |
Pharmaceutical Class | Bismuth [CS], Bismuth [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part335 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 68788-8128-03 (68788812803)
NDC Package Code | 68788-8128-3 |
---|---|
Billing NDC | 68788812803 |
Package | 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (68788-8128-3) |
Marketing Start Date | 2022-02-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL a8f6bd6f-e972-434e-b0de-ab65b67a1ce4 Details
Warnings
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Directions
- •
- drink plenty of clear fluids to help prevent dehydration caused by diarrhea
- •
- repeat dosage every 1/2 to 1 hour as needed
- •
- do not take more than 8 doses in 24 hours
- •
- use until diarrhea stops but not more than 2 days
- •
- adults and children 12 years and over: 2 tablets
- •
- children under 12 years: ask a doctor
Other information
Inactive ingredients
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
BISMUTH SUBSALICYLATE 262 MG
bismuth subsalicylate tablet, chewable |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
![]() |
||||||||||||||||||||
|
Labeler - Preferred Pharmaceuticals Inc. (791119022) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Preferred Pharmaceuticals Inc. | 791119022 | RELABEL(68788-8128) |